Riluzole is a medication used to slow the progression of Amyotrophic Lateral Sclerosis (ALS). It is an antagonist of the glutamate pathway and has shown to reduce excitability. Riluzole is the only medication that has shown to increase survival in patients with ALS. However, ALS is incurable and average span of disease is approximately 3 years from onset of symptoms.